HLB Pharmaceutical Co., Ltd. (047920)
Market Closed
11 Aug, 06:30
KRX SM KRX SM Primary ₩
8,740. 00
0
0%
₩
404.74B Market Cap
- P/E Ratio
- Div Yield
24,778 Volume
- Eps
₩ 8,740
Previous Close Want to track 047920 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
HLB Pharmaceutical Co., Ltd. (047920) Statistics
Valuation metrics
Market Cap 404.74B
Enterprise value 291.16B
Trailing P/E (ttm) 73.8
Forward P/E -
PEG ratio -2.42
Price/Sales (ttm) 1.16
Price/Book (mrq) 1.81
Enterprise Value/Revenue 1.23
Enterprise Value/EBITDA 40.22
Overview
Shares outstanding 32.8M
Float 26.93M
Shares short -
% Held by insiders 0.21%
% Held by institutions 0%
Average volume (10 days) 206.73K
Average volume (90 days) 249.11K
Price summary
52-Week low 6,000
52-Week high 22,250
Beta 1.83
50-Day moving average 9,845.72
200-Day moving average 14,114.67
Dividends and splits
Forward annual dividend rate 69.18
Forward annual dividend yield 0.0053%
Trailing annual dividend rate 16.2
Trailing annual dividend yield 0.0012%
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:1
Last split Date 12 Apr 2016
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Mar 2026
Profitability
Profit margin 0.02%
Operating margin 0%
Operational effectiveness
Return on assets 0.02%
Return on equity 0.03%
Income Statement
Revenue (ttm) 14.15B
Revenue per share (ttm) 7,213.17
Quarterly revenue growth (yoy) 0.92%
Gross profit (ttm) 1.1B
EBITDA 9.24B
Net income to common (ttm) -7.56B
Diluted EPS (ttm) 113.52
Quarterly earnings growth (yoy) 0.03%
Balance Sheet
Total cash (mrq) 22.14B
Total cash per share (mrq) 604.63
Total debt (mrq) 20.68B
Total Debt/Equity (mrq) 0.13
Current ratio (mrq) 1.9%
Book value per share (mrq) 4,626.03
Cash Flow
Cash flow statement -482.29M
Levered free cash flow (LFCF) -1.22B
